http://www.pharmaasia.comPharmaAsia - Drug Discoveryen-USCopyright 2012 Ten Alps Communications Asia. All rights reserved.Thu, 24 May 2012 12:42:05 +0800http://www.pharmaasia.com/article/apceth-indivumed-to-develop-biomarker-platform-for-targeted-cellular-therapies/9358apceth and Indivumed have entered into a partnership for the development of a predominantly tissue-based biomarker strategy for the treatment of solid cancers with cellular and / or gene therapeutics.http://www.pharmaasia.com/article/apceth-indivumed-to-develop-biomarker-platform-for-targeted-cellular-therapies/9358Tue, 27 Mar 2012 00:00:00 +0800http://www.pharmaasia.com/article/icon-to-support-study-evaluating-variability-in-insulin-secretory-parameters/9258Selected by Biomarkers Consortium of the FNIH.http://www.pharmaasia.com/article/icon-to-support-study-evaluating-variability-in-insulin-secretory-parameters/9258Fri, 21 Oct 2011 00:00:00 +0800http://www.pharmaasia.com/article/agilent-technologies-and-university-of-technology-sydney-open-joint-nuclear-magnet-resonance-facility/9256NMR facility will be home to cutting-edge technology to support a range of UTS staff and student research projects.http://www.pharmaasia.com/article/agilent-technologies-and-university-of-technology-sydney-open-joint-nuclear-magnet-resonance-facility/9256Thu, 20 Oct 2011 00:00:00 +0800http://www.pharmaasia.com/article/thermo-fisher-scientific-screening-library-advances-drug-discovery-research/925420,000-molecule Maybridge collection will help identify compound candidates to treat a wide range of diseases.http://www.pharmaasia.com/article/thermo-fisher-scientific-screening-library-advances-drug-discovery-research/9254Tue, 18 Oct 2011 00:00:00 +0800http://www.pharmaasia.com/article/progenra-and-ono-pharmaceutical-enter-into-research-collaboration/9250Progenra will collaborate with Ono to conduct assay development and high throughput screening by using Progenra’s proprietary technology on multiple targets in the ubiquitin pathway.http://www.pharmaasia.com/article/progenra-and-ono-pharmaceutical-enter-into-research-collaboration/9250Wed, 12 Oct 2011 00:00:00 +0800http://www.pharmaasia.com/article/agilent-technologies-supports-research-at-the-broad-institute/9242Developing proteomics technology to detect disease biomarkers.http://www.pharmaasia.com/article/agilent-technologies-supports-research-at-the-broad-institute/9242Wed, 12 Oct 2011 00:00:00 +0800http://www.pharmaasia.com/article/launch-of-biolynx-provides-a-boost-for-the-international-malaria-research-community/9241New NUS spin-off company launches at TechVenture 2011.http://www.pharmaasia.com/article/launch-of-biolynx-provides-a-boost-for-the-international-malaria-research-community/9241Wed, 12 Oct 2011 00:00:00 +0800http://www.pharmaasia.com/article/bi-axial-bioreactor-set-to-revolutionise-pre-clinical-trials-in-the-field-of-regenerative-medicine/9238Technology jointly developed by National University of Singapore and Singapore Polytechnic, and commercialised by local start-up company.http://www.pharmaasia.com/article/bi-axial-bioreactor-set-to-revolutionise-pre-clinical-trials-in-the-field-of-regenerative-medicine/9238Mon, 10 Oct 2011 00:00:00 +0800http://www.pharmaasia.com/article/india-generics-companies-lead-pharmaceutical-innovation-in-asia-pacific/9231Thomson Reuters Asia Pacific R&D Factbook details significant increases in innovation investment and development of novel drug pipelines.http://www.pharmaasia.com/article/india-generics-companies-lead-pharmaceutical-innovation-in-asia-pacific/9231Fri, 30 Sep 2011 00:00:00 +0800http://www.pharmaasia.com/article/ab-sciex-qtrap-technology-assists-yale-researchers-to-engineer-a-phosphoprotein/9229Synthetic biology-based approach successfully re-engineers protein-making mechanisms in bacteria.http://www.pharmaasia.com/article/ab-sciex-qtrap-technology-assists-yale-researchers-to-engineer-a-phosphoprotein/9229Thu, 29 Sep 2011 00:00:00 +0800